Skip to main content

Children and COVID Vaccines At A Glance:

  • FDA VRBPAC met for 2 days to discuss and approve Moderna 6 months to 17 years
  • Pfizer 6 months to 4 years also approved for EUA
  • Over 250 pages of data-dense documents were sent to the committee members just days before meetings to review
  • Discussions of childhood schedule already mentioned

This week, the FDA’s VRBPAC (Vaccines and Related Biological Products Advisory Committee) met on Tuesday and Wednesday to discuss all age brackets not yet covered by the Pfizer and Moderna COVID vaccines. VRBPAC would then decide whether to recommend that the FDA amend the Emergency Use Authorizations (EUAs) granted to the vaccines to cover these age groups.

The all-day meetings were held just days after the 190-page Moderna, and the additional 66-page Pfizer briefing documents, were released.

These documents were supplied to the advisory committee to review so that they could decide whether to vote on specific voting questions. The age groups for Moderna studies were broken down to 12-17 years and 6 months-11 years with subsets of the study focusing on 6-11 years, 2-5 years, and 6-23 months. The Pfizer vaccine was seeking its EUA for the final age group to be approved, the 6-23-month range.

If you missed the meetings and would like to watch the discussion, you can find the Tuesday and Wednesday ones on YouTube.

A Theatrical Show or Scientific Discussion?

As doctors and scientists raised questions to Dr. Arnold Monto, M.D., Acting Chair of VRBPAC, his common responses did one of three things:

  • Directed the doctors and scientists to the dense documents
  • Redirected to information that would be coming later in the meeting, or
  • Simply glossed over the questions, as data wasn’t verified, and information would be gathered post-market. (Meaning after the vaccine had been rolled out.)

Frequently, Dr. Monto gave the impression that he was more concerned about getting “to the bottom of the list” of people with questions than answering the questions they raised.

The same immunobridging method was used once again. In other words, they measured titers (presence and concentration of antibodies in blood) instead of the actual numbers of cases prevented to determine whether it would work in children.

Because the antibody titers closely reflected the data from the adult cohort study, they determined the vaccine would be effective. However, back in February, the consensus was that over 70% of children had natural immunity. The number of cases actually presented in both the placebo group and the vaccinated group were so low that they are virtually unusable data for determining efficacy.

What’s Next?

This committee unanimously voted to advise the FDA to approve the vaccines, which they did on Friday. The next step is for the CDC’s Advisory Committee on Immunization Practices (ACIP) committee to meet. That meeting is scheduled for Friday and Saturday. They will then advise the CDC on how the vaccines should be used and develop guidelines for clinics and pharmacies.

Finally, the CDC’s Rochelle Walensky will give her approval before children can begin receiving shots. Walensky’s signature is expected to come quickly after the CDC’s guidelines are set. The White House doesn’t want to waste any time getting shots into children’s arms. Per a June 9, 2022, statement:

The Administration has procured a significant supply of vaccines for this age group, with 10 million doses available initially and millions more available in the coming weeks.

Those vaccine doses were secured well before the approvals and recommendations were in place.

Hold the Phone — Doc’s Thoughts:

We knew this was coming. Doctors and scientists in the know have brought up the fact that many of these children have already been exposed to COVID and have natural immunity. Yet, the ugly truth behind vaccines is that these companies need to get these vaccines on the childhood schedule. In fact, in the meetings, it was brought up that since this is a multi-dose series, it likely should be added to the schedule so that they can ensure that people will complete the series. And that they’ll be completely liability-free forever.

Pfizer pulled back its EUA request in February when it became evident (for the second time) that the vaccine had failed. However, they just dosed these youngsters again, did another blood draw to check the antibodies they spiked, and called it good. Unfortunately, they still don’t acknowledge the risks involved, even though data has been piling up.

However, we have seen these vaccines fail again and again in adults. We know vaccine injury is real. Parents need to ask themselves how serious the risk of COVID is to their child and whether the risk of these and other vaccines is worth it. Don’t just read headlines. Read the documents, listen to the meetings, and research the vaccine injuries, so that you can make an informed, educated decision.

You still have the right to choose whether or not to vaccinate your child. Know that each time you go to the pediatrician after this, the pressure will be there. After all, how do you think they came up with the CDC schedule for well-child checkups?

If you would like to have your child’s immune response tested and learn to support their health, reach out to one of our clinics. We do health differently.


Subscribe to our newsletter for health tips & updates.

Join the community

Disclaimer: This content is for educational purposes only. It’s not intended as a substitute for the advice provided by your Wellness Way clinic or personal physician, especially if currently taking prescription or over-the-counter medications. Pregnant women, in particular, should seek the advice of a physician before trying any herb or supplement listed on this website. Always speak with your individual clinic before adding any medication, herb, or nutritional supplement to your health protocol. Information and statements regarding dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease.

Leave a Reply